DRUGS MADE IN AMERICA ACQUISITION II CORP.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | — | $-17.8M | $347.7K |
| Jun 2026 | — | $-17.9M | $175.0K |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | — | $-17.8M | $347.7K |
| Jun 2026 | — | $-17.9M | $175.0K |